Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro - Arai, M; Uchiba, M; Komura, H (J Pharmacol Exp Ther, 2010)
et al.